This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Horn, J. Articles by Limburg, M. Search for Related Content PubMed PubMed Citation Articles by Horn, J. Articles by Limburg, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Neuroprotectors Animal models of human disease Acute Cerebral Infarction

(Stroke. 2001;32:2433.)
© 2001 American Heart Association, Inc.

Comments, Opinions, and Reviews

Nimodipine in Animal Model Experiments of Focal Cerebral Ischemia

A Systematic Review

J. Horn, MD; R.J. de Haan, PhD; M. Vermeulen, MD; P.G.M. Luiten, PhD M. Limburg, MD

From the Department of Neurology (J.H., M.V.), the Department of Clinical Epidemiology and Biostatistics (R.J.d.H.), and the Department of Medical Informatics (M.L.), Academical Medical Center, University of Amsterdam, and the Department of Animal Physiology (P.G.M.L.), University of Groningen, Groningen, the Netherlands.

Correspondence to J. Horn, MD, Department of Neurology, AMC, PO Box 22700, 1100 DE, Amsterdam, Netherlands. E-mail jhorn{at}wxs.nl

Background and Purpose—— Based on the results of animal experiments, clinical trials were performed with nimodipine, which did not demonstrate a beneficial effect on outcome after stroke. The aim of this study was to determine whether the evidence from animal experiments with nimodipine supported the use of nimodipine in clinical trials.

Methods—— We performed a systematic review of animal experiments with nimodipine in focal cerebral ischemia. Studies were identified by searching Medline and Embase. We assessed whether these studies showed a beneficial effect of active treatment. In-depth analyses were performed on infarct size and amount of edema, and subgroup analyses were performed on the length of the time window to the initiation of treatment and the methodological quality of the studies.

Results—— Of 225 identified articles, 20 studies were included. The methodological quality of the studies was poor. Of the included studies, 50% were in favor of nimodipine. In-depth analyses showed statistically significant effects in favor of treatment (10 studies). No influence of the length of time to the initiation of treatment or of the methodological quality on the results was found.

Conclusions—— We conclude that the results of this review did not show convincing evidence to substantiate the decision to perform trials with nimodipine in large numbers of patients. There were no differences between the results of the animal experiments and clinical studies. Surprisingly, we found that animal experiments and clinical studies ran simultaneously.

Key Words: animal models • calcium channel blockers • cerebrovascular disorders • nimodipine • meta-analysis

This article has been cited by other articles:

				J. Minnerup, J. Heidrich, J. Wellmann, A. Rogalewski, A. Schneider, and W.-R. Schabitz Meta-Analysis of the Efficacy of Granulocyte-Colony Stimulating Factor in Animal Models of Focal Cerebral Ischemia Stroke, June 1, 2008; 39(6): 1855 - 1861. [Abstract] [Full Text] [PDF]

				N. A. Crossley, E. Sena, J. Goehler, J. Horn, B. van der Worp, P. M.W. Bath, M. Macleod, and U. Dirnagl Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach Stroke, March 1, 2008; 39(3): 929 - 934. [Abstract] [Full Text] [PDF]

				E. Sena, P. Wheble, P. Sandercock, and M. Macleod Systematic Review and Meta-Analysis of the Efficacy of Tirilazad in Experimental Stroke Stroke, February 1, 2007; 38(2): 388 - 394. [Abstract] [Full Text] [PDF]

				R. Lemon and S. B Dunnett Surveying the literature from animal experiments BMJ, April 30, 2005; 330(7498): 977 - 978. [Full Text] [PDF]

				L. E. Mignini, P. M. Latthe, J. Villar, M. D. Kilby, G. Carroli, and K. S. Khan Mapping the Theories of Preeclampsia: The Role of Homocysteine Obstet. Gynecol., February 1, 2005; 105(2): 411 - 425. [Abstract] [Full Text] [PDF]

				M. R. Macleod, T. O'Collins, D. W. Howells, and G. A. Donnan Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias Stroke, May 1, 2004; 35(5): 1203 - 1208. [Abstract] [Full Text] [PDF]

				P. Pound, S. Ebrahim, P. Sandercock, M. B Bracken, and I. Roberts Where is the evidence that animal research benefits humans? BMJ, February 28, 2004; 328(7438): 514 - 517. [Full Text] [PDF]

				P. Pound and S. Ebrahim Supportive evidence is lacking for report on animal studies BMJ, November 2, 2002; 325(7371): 1038 - 1038. [Full Text]

				D. J. Gladstone, S. E. Black, and A. M. Hakim Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions Stroke, August 1, 2002; 33(8): 2123 - 2136. [Abstract] [Full Text] [PDF]

				I. Chalmers, L. V. Hedges, and H. Cooper A Brief History of Research Synthesis Eval Health Prof, March 1, 2002; 25(1): 12 - 37. [Abstract] [PDF]